Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- OSN round table, part 2: Optimization of the ocular surface
-
- AAO report: Limited high-level evidence for long-term benefit of NSAIDs after cataract surgery
- Anti-VEGF treatment may benefit patients with DME, vitreomacular adhesions
- Benefits of cross-linking go beyond stopping progression of keratoconus
- Enrollment completed for PMA arm of first US clinical trial of artificial iris
- Femtosecond LASIK with novel settings improves vision in eyes with previous RK
- OSN talks with Allergan CEO about Pfizer merger, days ahead
- How to approach a complex cataract case Uday Devgan, MD
- Questions abound when faced with issue of genetic testing Lisa K. Feulner, MD, PhD
-
- Man presents with 2-month history of declining vision Jeffrey Chang, MD; Melina I. Morkin, MD; Jeffrey L. Marx, MD
- IC-8 IOL may improve range of focal distances in cataract patients
- Improved topography, wavefront parameters sustained up to 7 years after cross-linking
- ‘No-talking’ policy may reduce endophthalmitis risk after intravitreal injection
- Topical NSAIDs may lessen odds of cystoid macular edema after cataract surgery
- Trabeculectomy has little impact on IOL power calculations
- Visual outcomes, safety similar in aspheric-customized LASIK, wavefront-optimized LASIK
- Ocular surface disease: One physician’s approach to treatment Richard L. Lindstrom, MD
-
- Extended indications for anti-VEGF treatment in proliferative diabetic retinopathy will affect services, costs
- Issues with safety of anti-VEGF agents in infants with ROP call for further investigation
- Keynote lecture explores modular organization of visual brain
- OCTA shows in vivo alterations of retinal capillary network in diabetic eyes
- Protocol S evidence expands role of anti-VEGF in proliferative diabetic retinopathy, but laser still useful
- A thankful beginning to the new year Darrell E. White, MD